Edition:
United States

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

14.88USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$14.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
44,377
52-wk High
$16.61
52-wk Low
$7.21

Chart for

About

Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast... (more)

Overall

Beta: --
Market Cap(Mil.): $288.60
Shares Outstanding(Mil.): 19.40
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 58.86 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 35.70
ROE: -- 19.82 15.40

BRIEF-Sientra posts qtrly loss of $0.74​ per share

* Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016​

Nov 07 2017

BRIEF-Sientra's ‍total net sales for Q3 2017 were $9.8 million

* Sientra - ‍total net sales for Q3 2017 were $9.8 million, compared to $6.5 million for same period in 2016

Nov 07 2017

BRIEF-Sientra reports Q2 net loss per share attributable to stockholders $1.07​

* Sientra Inc qtrly ‍basic and diluted net loss per share attributable to common stockholders $1.07​ Source text for Eikon: Further company coverage:

Aug 09 2017

BRIEF-Sientra, Silimed reach settlement of lawsuit and related arbitration

* Sientra says on June 27, co, Silimed Ind*A De Implantes Ltda reached settlement of lawsuit and related arbitration between them - SEC filing

Aug 01 2017

BRIEF-Sientra Inc says amendment permits merger to be effected as a "short-form" merger‍​

* Sientra Inc - co, Desert Acquisition Corp and Miramar Labs Inc. Entered into amendment no. 1 to agreement and plan of merger

Jun 26 2017

Earnings vs. Estimates